雲水喫茶の日替りマスター!!

A medicine related to Japan

A nurse friend of mine told me about a medicine related to Japan, called "ivermectin". 

In Tokyo, doctors at Kitasato University are looking for people to help them conduct a clinical trial of this medicine. 

Honestly, I don't know much about this medicine in detail, but from what I could find out briefly, I feel it has the potential to break the current situation, so I'll share it here.

They are looking for test subjects in Tokyo, and I have passed this information on to two people I know who have tested positive. 


If you have a connection to Japan and possibly have any idea, please share the information to someone who can help Kitasato Univ with the clinical trial. I would appreciate it if you would consider this, Thanks!

Seigaku with prayers

Contact
Kitasato Research Institute
5-9-1 Shirokane, Minato-ku, Tokyo 108-8641
TEL: 03-5791-6422
E-mail:kohoh "AT "kitasato-u.ac.jp
Please change "AT" to "@" in the e-mail address above.



Reference links

Ivermectin - Wikipedia

The original japanese text from Kitasato Research Institute




The following is my personal summary and translation of the original text from Kitasato Univ with the help of machine translation

----------------------
A call center has been set up to recruit patients who are willing to cooperate in the clinical trial about Ivermectin Clinical Trials.

Kitasato University Hospital(KUH) has set up a call center on June 17, 2021 to promote the clinical trial of ivermectin for new coronavirus infection (COVID-19).

With the aim of recruiting subjects in Tokyo, KUH plan to start with Minato and Suginami wards, which are in the vicinity of the medical institutions where the clinical trials will be conducted, and expand the system to the rest of Tokyo as needed.

This clinical trial started in September 2020 with the aim of adding an indication for ivermectin for the treatment of new coronavirus infections, and is being conducted with the support of many people. 

However, the number of registered cases has just exceeded half of the planned number as of June 2021, due to the impact of tight medical care caused by the nationwide spread of the new coronavirus infection.

In light of this situation, in order to complete this clinical trial as soon as possible, with the cooperation of the Tokyo Metropolitan Medical Association, we have started to operate a system for recruiting patients through a call center in Tokyo.

We will continue our efforts to achieve the target number of patients so that we can complete this clinical trial as soon as possible.

For inquiries, please contact
Kitasato Research Institute
5-9-1 Shirokane, Minato-ku, Tokyo 108-8641
TEL: 03-5791-6422
E-mail:kohoh "AT "kitasato-u.ac.jp
Please change "AT" to "@" in the e-mail address above.

IMG_6105.JPG

2021/08/01  by

コメントする